Venture Certified
| 혁신성장유형 | 2026-02-24 ~ 2029-02-23 | 20260224030016 | 2026-02-24 |
Revenue CAGR +26.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 2.7B | 3.0B | 1.7B |
| Operating Profit | 0.1B | 0.4B | -0.3B |
| Net Profit | 0.0B | 0.4B | -0.3B |
| Total Assets | 8.0B | 2.4B | 2.4B |
| Total Liabilities | 7.0B | 1.5B | 1.9B |
| Total Equity | 1.0B | 1.0B | 0.5B |
Debt Ratio 704.2%: Exceeds 400%, financial soundness risk
Debt Ratio Surge (+554pp YoY)
▲ 14.2%
▲ 26.5%
▲ 243.2%
▲ 181.9%
▲ 166.1%
| Name | Position | Role |
|---|---|---|
| 최성준 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청남도 천안시",
"ceo_name": "최성준",
"certificate": [
{
"cert_number": "20260224030016",
"changes": "",
"disclosure_date": "2026-02-24",
"first_cert_date": "2026-02-24",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2026-02-24 ~ 2029-02-23"
}
],
"company_name": "(주)엠디에이아이",
"corp_no": "161511-*******",
"financials": {
"2022": {
"capital_stock": 50000000,
"cost_of_sales": 0,
"current_assets": 85822000,
"current_liabilities": 187321000,
"gross_profit": 168182000,
"net_income": -30955000,
"net_income_bs": -30955000,
"non_current_assets": 155114000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 87000,
"operating_profit": -31042000,
"revenue": 168182000,
"sga_expenses": 199224000,
"total_assets": 240936000,
"total_equity": 53615000,
"total_liabilities": 187321000
},
"2023": {
"capital_stock": 50000000,
"cost_of_sales": 0,
"current_assets": 109359000,
"current_liabilities": 146097000,
"gross_profit": 304000000,
"net_income": 43603000,
"net_income_bs": 43603000,
"non_current_assets": 133956000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 0,
"operating_profit": 43603000,
"revenue": 304000000,
"sga_expenses": 260397000,
"total_assets": 243315000,
"total_equity": 97218000,
"total_liabilities": 146097000
},
"2024": {
"capital_stock": 50000000,
"cost_of_sales": 0,
"current_assets": 353809000,
"current_liabilities": 401221000,
"gross_profit": 269555000,
"net_income": 4241000,
"net_income_bs": 2360000,
"non_current_assets": 446991000,
"non_current_liabilities": 300000000,
"non_operating_expenses": 3836000,
"non_operating_income": 135000,
"operating_profit": 7942000,
"revenue": 269555000,
"sga_expenses": 261613000,
"total_assets": 800800000,
"total_equity": 99579000,
"total_liabilities": 701221000
}
},
"industry": "그 외 기타 분류 안된 전문, 과학 및 기술 서비스업",
"investment": [],
"main_products": "의학 및 약학 연구개발업",
"phone": "010-3638-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |